Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. David Kindness is a Certified Public ...
17h
WisdomTree (WT): $35.5M One-Off Loss Cuts Profit Margins, Challenges Optimistic Earnings Narratives
WisdomTree (WT) posted revenue growth of 10.2% per year, narrowly lagging the broader US market’s 10.3% forecast. EPS is set to climb 14.5% annually, also coming in just under the market’s 15.9% pace, ...
When managing projects, every decision you make—especially financial ones—has long-term consequences. One of the most ...
Travere Therapeutics (TVTX) continues to operate at a loss, with net losses expanding at an average annual rate of 11.7% over the past five years. However, the outlook for earnings is robust, with ...
Chinese equities may be undervalued compared to booming US indices. Learn how shifts in sentiment could impact the Hang Seng ...
Third quarter revenue of $768 million, up 5.9%, and up 5.5% on an organic constant currency (OCC) basis.Net income of $226 million, up 2.5% as ...
Ares Capital is the sector's benchmark BDC, currently trading near NAV with a strong credit rating and historical returns.
Q3 Net Revenue of $3.1 billion with 21.2 million Active Customers BOSTON, Oct. 28, 2025 /PRNewswire/ -- Wayfair Inc. ("Wayfair," "we," or "our") (NYSE: W), the ...
Eyewear retailer Lenskart Solutions is all set to launch its much-awaited initial public offering (IPO) on October 31, 2025, ...
Third quarter revenue of $768 million, up 5.9%, and up 5.5% on an organic constant currency (OCC) basis.Net income of $226 million, up 2.5% as strong operating performance were partially offset by hig ...
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced its results for the third quarter ended September 30, 2025. “Amneal delivered another strong quarter and updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback